4.7 Article

ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study

Sanaz Sedaghat et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2016)

Article Hematology

Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity

K. South et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)

Article Public, Environmental & Occupational Health

The Rotterdam Study: 2016 objectives and design update

Albert Hofman et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2015)

Article Biochemistry & Molecular Biology

ADAMTS13 and its variants promote angiogenesis via upregulation of VEGF and VEGFR2

Manfai Lee et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2015)

Article Multidisciplinary Sciences

Conformational activation of ADAMTS13

Kieron South et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Editorial Material Endocrinology & Metabolism

Can ADAMTS13 Lead Us to the Paradise of Personalized Medicine?

Peter Rossing et al.

DIABETES (2013)

Article Cardiac & Cardiovascular Systems

Hypertensive target organ damage predicts incident diabetes mellitus

Raffaele Izzo et al.

EUROPEAN HEART JOURNAL (2013)

Article Hematology

Microvascular Dysfunction Is Associated With a Higher Incidence of Type 2 Diabetes Mellitus A Systematic Review and Meta-Analysis

Dennis M. J. Muris et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)

Article Public, Environmental & Occupational Health

Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study

Maarten J. G. Leening et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2012)

Article Multidisciplinary Sciences

Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes

Carolina E. Hagberg et al.

NATURE (2012)

Article Clinical Neurology

High von Willebrand Factor Levels Increase the Risk of Stroke The Rotterdam Study

Renske G. Wieberdink et al.

STROKE (2010)

Article Hematology

Association between reduced ADAMTS13 and diabetic nephropathy

Shotaro Taniguchi et al.

THROMBOSIS RESEARCH (2010)

Article Cardiac & Cardiovascular Systems

Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients

T. N. Bongers et al.

ATHEROSCLEROSIS (2009)

Editorial Material Medicine, Research & Experimental

Type 2 diabetes: Microvascular ischemia of pancreatic islets?

Michael G. Tal

MEDICAL HYPOTHESES (2009)

Article Endocrinology & Metabolism

Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men

S. Goya Wannamethee et al.

DIABETES CARE (2008)

Article Hematology

FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay

K Kokame et al.

BRITISH JOURNAL OF HAEMATOLOGY (2005)